Last update :
19/11/2024
References   References 3711  
Type : Manufacturer

Research teams :
Authors :
Title : Vedolizumab (Entyvio®) - Summary of Product Characteristics
Reference : Takeda 2015

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionVedolizumab Immunosuppressant
Stability in solutions Not specified Sodium chloride 0,9% 1.2 mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Sodium chloride 0,9% 1.2 mg/ml 20-25°C Not specified
12 Hour

  Mentions Légales